[ad_1]
Teva's lobbying expenses of $ 1.6 million in the first half of 2018 are down 54% from the same period in 2017.
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) reported to the US authorities that he spent $ 1.1 million in lobbying in the second quarter of 2018. It is higher than the second quarter of 2017, when the Israeli company spent $ 840,000 and more than the first quarter of 2018 when Teva spent $ 480,000 on lobbying. However, Teva's lobbying expenses of $ 1.6 million in the first half of 2018 are down 54% from the corresponding period of 2017.
RELATED ARTICLES
Kare Schultz Photo credit: PR
[19659014]
[ad_2]
Source link
Tags Billion lobbying quarter reaches spending States Teva United
